ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2800

Five Year Structural Changes in Patients with Meniscal Tear and Osteoarthritis from an RCT of Arthroscopic Partial Meniscectomy vs. Physical Therapy

Swastina Shrestha1, Jeffrey Katz 2, Elena Losina 3 and Jamie Collins 4, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital/Harvard Medical School, Boston, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: meniscectomy, meniscus, osteoarthritis and MRI, physical therapy

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

Session Type: ACR/ARP Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Meniscal tear is an independent risk factor of structural progression in OA; Arthroscopic partial meniscectomy (APM) is also associated with progression, though it is unclear if APM confers additional risk beyond that of the underlying meniscal tear. The goal of this study was to evaluate changes in knee MRI findings over 60 months in patients with meniscal tear and OA treated with either APM (and postop physical therapy (PT)) or with PT alone as a part of a multicenter RCT.

Methods: We used data from an RCT of APM and PT vs. PT alone (denoted in this abstract as APM vs. PT) for patients ≥ 45 years old with knee pain, meniscal tear on MRI, and OA changes on radiograph or MRI. Patients were excluded from this analysis if they were randomized to but did not receive APM, crossed over to APM > 6 months from randomization, or if they had no MRIs. We performed as-treated analysis: subjects who crossed over from PT to APM within 6 months from randomization were analyzed in the APM group.

Baseline (BL), 18-month (18m), and 60-month (60m) MRIs were read using the MRI OA Knee Score (MOAKS), which assesses damage in several joint features including osteophyte, cartilage surface area, and cartilage thickness. Each feature was scored ordinally from 0 – 3, (higher is worse) in each of 14 subregions (SR) for cartilage and 12 for osteophytes. We summed the scores from all SRs within the osteophyte, cartilage surface area and cartilage thickness domains. We used a linear mixed effects model to assess the relationship between the APM and PT groups and the changes in damage scores within each domain for two time intervals: BL-18m and 18m-60m.

Results: Of 351 randomized subjects, we excluded 10 randomized to but not undergoing APM, 14 randomized to PT who crossed over after 6m and 32 with no MRI. The analytic cohort included 295 subjects with mean age 58 (SD 7) years and mean baseline KOOS pain (0-100, 100 worst) 47 (SD 16). 193 (65%) received APM and 102 (35%) received PT. The groups were balanced on BL demographic and clinical characteristics. 285 (97%) subjects had MRI at BL 221 (75%) at 18m and 165 (56%) at 60m.

Descriptive statistics on change in both time periods are presented in the Table. Both treatment groups worsened in all domains for both time periods, with more worsening over BL – 18m than 18m – 60m. The Figure displays the difference in change in score for each domain for APM vs. PT, from the mixed effects model. Worsening in osteophyte score was significantly greater in the APM group vs. the PT group for both time periods. Change in both cartilage surface area and cartilage thickness scores were significantly different between the groups for the BL – 18m period, but not the 18m – 60m period.

Conclusion: In subjects with underlying meniscal tear, APM was associated with greater worsening in cartilage surface area, cartilage thickness, and osteophytes over 18m post randomization, and greater worsening in osteophytes, but not in cartilage scores, in the subsequent 42 months. Future work will consider missing not at random imputation for subjects undergoing TKR, examine outcomes from an intention to treat perspective, and determine the magnitude of change in structure that is associated with clinically meaningful changes in symptoms.


Table 1

Table.


Figure

Figure


Disclosure: S. Shrestha, Roche/Genentech, 2; J. Katz, Flexion, 2, Flexion Therapeutics, 2, Samumed, 2; E. Losina, Flexion, 2, Flexion Therapeutics, 2, Pfizer, 2, Pfizer Inc, 2, Regeneron, 5, Regeneron Pharmaceuticals, 5, Roche/Genentech, 2, Samumed, 2, TissueGene, 2, Velocity, 5, Velocity Pharaceutical Development, 5, Velocity Pharmaceutical Development, 5; J. Collins, Boston Imaging Core Lab, 5, Boston Imaging Core Labs, 2, Genentech, 2, Roche/Genentech, 2.

To cite this abstract in AMA style:

Shrestha S, Katz J, Losina E, Collins J. Five Year Structural Changes in Patients with Meniscal Tear and Osteoarthritis from an RCT of Arthroscopic Partial Meniscectomy vs. Physical Therapy [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/five-year-structural-changes-in-patients-with-meniscal-tear-and-osteoarthritis-from-an-rct-of-arthroscopic-partial-meniscectomy-vs-physical-therapy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/five-year-structural-changes-in-patients-with-meniscal-tear-and-osteoarthritis-from-an-rct-of-arthroscopic-partial-meniscectomy-vs-physical-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology